Sirton Pharmaceuticals Overview

  • Year Founded
  • 1944

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 109

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

Sirton Pharmaceuticals General Information

Description

Operator of a pharmaceutical contract manufacturing company intended to serve the healthcare sector. The company produces injectable pharma products, including pre-filled syringes, liquid vials, freeze-dried vials and ampoules and provides pharmaceutical development services including lyophilization process development, analytical method development and validation, stability studies and manufacturing of clinical study materials, thereby enabling clients with precise products as per their requirements.

Contact Information

Website
www.sirton.it
Formerly Known As
Crinos Industria Farmacobiologica
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Piazza XX Settembre, 2
  • 22079 Villa Guardia
  • Italy
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • Piazza XX Settembre, 2
  • 22079 Villa Guardia
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sirton Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sirton Pharmaceuticals‘s full profile, request access.

Request a free trial

Sirton Pharmaceuticals Patents

Sirton Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2242329-T3 Agents and compositions of the same for hair treatment, containing depolimerized fucano sulphates. Inactive 16-Jun-1998
EP-0965323-A2 Agents and compositions thereof for the hair treatment containing depolymerized fucane sulphates Active 16-Jun-1998
EP-0965323-A3 Agents and compositions thereof for the hair treatment containing depolymerized fucane sulphates Active 16-Jun-1998
EP-0965323-B1 Agents and compositions thereof for the hair treatment containing depolymerized fucane sulphates Inactive 16-Jun-1998
EP-0849280-A2 Fucans with low molecular weight having anticoagulant, antithrombinic and antithrombotic activity Active 18-Dec-1996 A61K31/737
To view Sirton Pharmaceuticals’s complete patent history, request access »

Sirton Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sirton Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sirton Pharmaceuticals‘s full profile, request access.

Request a free trial

Sirton Pharmaceuticals FAQs

  • When was Sirton Pharmaceuticals founded?

    Sirton Pharmaceuticals was founded in 1944.

  • Where is Sirton Pharmaceuticals headquartered?

    Sirton Pharmaceuticals is headquartered in Villa Guardia, Italy.

  • What is the size of Sirton Pharmaceuticals?

    Sirton Pharmaceuticals has 109 total employees.

  • What industry is Sirton Pharmaceuticals in?

    Sirton Pharmaceuticals’s primary industry is Drug Delivery.

  • Is Sirton Pharmaceuticals a private or public company?

    Sirton Pharmaceuticals is a Private company.

  • What is Sirton Pharmaceuticals’s current revenue?

    The current revenue for Sirton Pharmaceuticals is .

  • Who are Sirton Pharmaceuticals’s investors?

    First Shanghai and STADA Arzneimittel have invested in Sirton Pharmaceuticals.

  • When was Sirton Pharmaceuticals acquired?

    Sirton Pharmaceuticals was acquired on 31-Dec-2014.

  • Who acquired Sirton Pharmaceuticals?

    Sirton Pharmaceuticals was acquired by 3Sbio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process